FP 50 restriction sparks prescribing authority debate – RACGP
‘Either the treatment is appropriate and evidence-based or not. … and cost with that of alternative treatments,’ the spokesperson said.
‘Either the treatment is appropriate and evidence-based or not. … and cost with that of alternative treatments,’ the spokesperson said.